Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility
Loredana Cavalli, Maria Luisa BrandiUnit of Mineral and Bone Metabolism Diseases, Department of Internal Medicine, Traumatologic Orthopedic Center, Florence, ItalyAbstract: Denosumab is a breakthrough biological drug approved by the Food and Drug Administration and European Medicines Agency for the...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2012-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!